Patents by Inventor Todd Bernard PARSLEY

Todd Bernard PARSLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment delivery system and method
    Publication number: 20230285508
    Abstract: Compositions for a phage particle are disclosed. The phage particle is non-replicating and includes at least one heterologous nucleic acid sequence that is capable of being expressed in a target bacteria. The expressed heterologous nucleic acid sequence is non-lethal to the target bacteria.
    Type: Application
    Filed: May 17, 2023
    Publication date: September 14, 2023
    Applicant: SynPhaGen LLC
    Inventors: Todd Bernard Parsley, Christian Furlan Freguia
  • Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
    Publication number: 20190315642
    Abstract: Compositions for a phage particle are disclosed. The phage particle is non-replicating and includes at least one heterologous nucleic acid sequence that is capable of being expressed in a target bacteria. The expressed heterologous nucleic acid sequence is non-lethal to the target bacteria.
    Type: Application
    Filed: June 3, 2019
    Publication date: October 17, 2019
    Applicant: SynPhaGen LLC
    Inventors: Todd Bernard Parsley, Christian Furlan Freguia
  • Compositions for in vivo expression of therapeutic sequences in the microbiome
    Patent number: 10351452
    Abstract: Compositions for a phage particle are disclosed. The phage particle is non-replicating and includes at least one heterologous nucleic acid sequence that is capable of being expressed in a target bacteria. The expressed heterologous nucleic acid sequence is non-lethal to the target bacteria.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: July 16, 2019
    Assignee: SynPhaGen LLC
    Inventors: Todd Bernard Parsley, Christian Furlan Freguia
  • Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses
    Patent number: 9676641
    Abstract: Compositions for a phage particle are disclosed. The phage particle is non-replicating and includes at least one heterologous nucleic acid sequence that is capable of being expressed in a target bacteria. The expressed heterologous nucleic acid sequence is non-lethal to the target bacteria.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: June 13, 2017
    Assignee: SynPhaGen LLC
    Inventors: Todd Bernard Parsley, Christian Furlan Freguia
  • Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
    Publication number: 20160367701
    Abstract: Compositions for a phage particle are disclosed. The phage particle is non-replicating and includes at least one heterologous nucleic acid sequence that is capable of being expressed in a target bacteria. The expressed heterologous nucleic acid sequence is non-lethal to the target bacteria.
    Type: Application
    Filed: January 26, 2015
    Publication date: December 22, 2016
    Applicant: SynPhaGen LLC
    Inventors: Todd Bernard Parsley, Christian Furlan Freguia
  • THERAPEUTIC PHAGES AND METHODS FOR DELIVERY OF NUCLEIC ACIDS FOR THERAPEUTIC USES
    Publication number: 20160160186
    Abstract: Compositions for a phage particle are disclosed. The phage particle is non-replicating and includes at least one heterologous nucleic acid sequence that is capable of being expressed in a target bacteria. The expressed heterologous nucleic acid sequence is non-lethal to the target bacteria.
    Type: Application
    Filed: January 26, 2015
    Publication date: June 9, 2016
    Inventors: Todd Bernard PARSLEY, Christian Furlan FREGUIA